← Open Payments lookup

MIKSHIRA MOSELY: Open Payments

NPI 1780160606 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,216 in 21 payments from 17 companies in 2025. Trend: 2023 $1,442 · 2024 $1,639 · 2025 $2,216

Food & beverage: $2,216
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.2$250
Dexcom, Inc.1$163
Janssen Pharmaceuticals, Inc1$150
Bayer Healthcare Pharmaceuticals Inc.1$140
Janssen Biotech, Inc.1$137
Exact Sciences Corporation2$132
Amgen Inc.1$127
GENZYME CORPORATION1$125
AstraZeneca Pharmaceuticals LP1$125
Novo Nordisk Inc1$123

Products named: FANAPT, DEXCOM G7 GSS (161), SPRAVATO, Kerendia, KRYSTEXXA, DUPIXENT, Wegovy, REZDIFFRA.

Industry payments across LA — which companies pay providers there.